Total Payments
$7,419
2024 Payments
$1,300
Companies
64
Transactions
433
Medicare Patients
1,194
Medicare Billing
$129,735
Payment Breakdown by Category
Food & Beverage$7,187 (96.9%)
Education$125.06 (1.7%)
Other$107.15 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,187 | 424 | 96.9% |
| Education | $125.06 | 4 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $107.15 | 5 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $647.19 | 55 | $0 (2024) |
| UCB, Inc. | $507.32 | 25 | $0 (2024) |
| Biogen, Inc. | $502.56 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $500.31 | 26 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $401.61 | 45 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $387.31 | 17 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $288.54 | 10 | $0 (2024) |
| Lundbeck LLC | $264.16 | 14 | $0 (2024) |
| Amgen Inc. | $231.09 | 9 | $0 (2024) |
| GENZYME CORPORATION | $222.06 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,300 | 64 | ABBVIE INC. ($211.51) |
| 2023 | $937.64 | 55 | ABBVIE INC. ($220.07) |
| 2022 | $940.69 | 57 | Biogen, Inc. ($141.11) |
| 2021 | $554.21 | 31 | GE HEALTHCARE ($63.85) |
| 2020 | $568.45 | 32 | UCB, Inc. ($62.36) |
| 2019 | $1,576 | 107 | Alnylam Pharmaceuticals Inc. ($161.15) |
| 2018 | $881.37 | 52 | Amgen Inc. ($153.14) |
| 2017 | $660.16 | 35 | Stryker Corporation ($115.42) |
All Payment Transactions
433 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.54 | General |
| 12/05/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Genetic Disease | ||||||
| 11/22/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.43 | General |
| 10/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/15/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: EPILEPSY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: Neurology | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Neurology | ||||||
| 09/26/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Neurology | ||||||
| 09/05/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Rare Disease | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Neurology | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.94 | General |
| Category: NEUROLOGY | ||||||
| 07/18/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $30.28 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 227 | 280 | $88,439 | $22,341 |
| 2022 | 8 | 320 | 392 | $123,517 | $33,940 |
| 2021 | 7 | 238 | 299 | $101,920 | $30,300 |
| 2020 | 11 | 409 | 509 | $160,488 | $43,153 |
Total Patients
1,194
Total Services
1,480
Medicare Billing
$129,735
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 49 | 87 | $23,925 | $6,209 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 47 | $12,220 | $3,969 | 32.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 22 | 22 | $17,380 | $3,916 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $13,035 | $3,019 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 51 | $8,925 | $2,772 | 31.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 17 | 18 | $12,690 | $2,271 | 17.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 22 | $264.00 | $184.80 | 70.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 68 | 112 | $30,800 | $8,439 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 82 | $21,320 | $6,646 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $22,910 | $6,385 | 27.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 26 | 26 | $20,540 | $4,455 | 21.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 21 | 21 | $14,805 | $3,505 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 54 | $9,450 | $3,447 | 36.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $3,380 | $985.24 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 26 | $312.00 | $77.01 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 81 | $21,060 | $7,865 | 37.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 56 | 95 | $26,125 | $7,495 | 28.7% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 22 | 22 | $17,380 | $4,157 | 23.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 24 | 24 | $16,920 | $4,000 | 23.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $10,665 | $3,398 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 38 | $6,650 | $2,488 | 37.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,120 | $897.74 | 28.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 76 | 131 | $34,825 | $9,757 | 28.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 108 | $28,080 | $7,660 | 27.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 66 | 66 | $26,070 | $7,524 | 28.9% |
About Donika Patel
Donika Patel is a Neurology healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2009. The National Provider Identifier (NPI) number assigned to this provider is 1508006776.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Donika Patel has received a total of $7,419 in payments from pharmaceutical and medical device companies, with $1,300 received in 2024. These payments were reported across 433 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($7,187).
As a Medicare-enrolled provider, Patel has provided services to 1,194 Medicare beneficiaries, totaling 1,480 services with total Medicare billing of $129,735. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Greensboro, NC
- Active Since 03/02/2009
- Last Updated 09/20/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1508006776
Products in Payments
- NUPLAZID (Drug) $401.61
- Briviact (Drug) $328.86
- ONPATTRO (Drug) $288.54
- QULIPTA (Drug) $283.95
- VUMERITY (Drug) $231.26
- UBRELVY (Drug) $214.41
- BOTOX (Biological) $206.60
- KESIMPTA (Drug) $199.18
- ULTOMIRIS (Biological) $198.46
- VYEPTI (Biological) $193.28
- TYSABRI (Biological) $192.40
- ACTHAR (Biological) $172.31
- Gamunex-C (Biological) $152.50
- Aimovig (Biological) $127.66
- Radicava (Drug) $119.49
- SOLIRIS (Drug) $117.56
- GILENYA (Drug) $116.16
- Custom Implants (Device) $115.42
- XEOMIN (Biological) $109.08
- INBRIJA (Drug) $107.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Greensboro
Dr. Pramodkumar Sethi, M.d, M.D
Neurology — Payments: $69,973
Neurology $69,973
Dr. Carmen Dohmeier, M.d, M.D
Neurology — Payments: $14,830
Neurology $14,830
Yijun Yan, Md, MD
Neurology — Payments: $12,473
Neurology $12,473
Dr. Adam Jaffe, D.o, D.O
Neurology — Payments: $10,635
Neurology $10,635
Saima Athar, M.d, Phd, M.D, PHD
Neurology — Payments: $9,443
Neurology $9,443
Karen Aquino, M.d, M.D
Neurology — Payments: $9,199
Neurology $9,199